Jones Financial Companies’s Cidara Therapeutics CDTX Stock Holding History

Jones Financial Companies’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-25	Closed	-$5.52K	–	4758
2025 Q4	$5.52K	Sell	25 -100	-80%	-$16.2K	﹤0.01%	3457
2025 Q3	$11.3K	Buy	+125	New	+$7.98K	﹤0.01%	3035

Jones Financial Companies's CDTX Position: Q1 2026 in Review

Jones Financial Companies sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 25 shares — an estimated $5.52K sold.

Jones Financial Companies first reported a position in CDTX in Q3 2025 and held it in 2 quarters. The position peaked at $11.3K in Q3 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Jones Financial Companies reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Jones Financial Companies sold 25 Cidara Therapeutics shares in Q1 2026, an estimated $5.52K.
Jones Financial Companies first reported a position in Cidara Therapeutics in Q3 2025 and held it in 2 quarters.
Jones Financial Companies's Cidara Therapeutics position peaked at $11.3K in Q3 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.